Emergence of < em > TP53 < /em > mutation during lenalidomide therapy of myelodysplastic syndrome with del(5q) and its subsequent disappearance following salvage therapy with decitabine

Haematologica. 2023 Nov 30. doi: 10.3324/haematol.2023.284547. Online ahead of print.ABSTRACTNot available.PMID:38031760 | DOI:10.3324/haematol.2023.284547

Source: Haematologica - November 30, 2023 Category: Hematology Authors: Naseema Gangat Naresh Bellam Kaaren Reichard Ayalew Tefferi Source Type: research